EU-AIMS Best performing IMI project according Reuters Research

EU-AIMS Best performing IMI project according Reuters Research

In a bibliometric analysis of ongoing IMI projects EU-AIMS in it's short life was rated the best IMI project on various performance measures. 

On scientific output:

• EU-AIMS has the highest citation impact to date of all IMI projects and 4 times the world average impact.
• EU-AIMS has the highest percentage of highly cited papers (42% of EU-AIMS publications are in the top decile of publications for journal category and year of publication).

On interactions with distinct stakeholders:

• External funding/support from Autism speaks and other advocacy organisations and interactions with key regulatory agencies such as EMA and FDA

For more specific details: http://www.imi.europa.eu/sites/default/files/uploads/documents/BibliometricReport4_Final.pdf